| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hebbar Sudarshan | Chief Medical Officer | C/O CALCIMEDICA, INC., 505 COAST S. BLVD. #307, LA JOLLA | /s/ John Dunn, Esq., Attorney-in-Fact | 21 Aug 2025 | 0001968793 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CALC | Common Stock | Purchase | $26,962 | +9,563 | +18% | $2.82 | 61,539 | 19 Aug 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The weighted average purchase price for the transaction reported was $2.8194, and the range of prices were between $2.74 and $2.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |